Concerto HealthAI is a technology leader in Real-World Data (RWD) and AI solutions for precision oncology. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is on revolutionizing clinical and outcomes research to accelerate the insights benefiting patient treatment.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/13/20 | $150,000,000 | Series B |
Alliance Bernstein PCI Declaration Partners  Maverick Ventures SymphonyAI Group | undisclosed |
